Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial
ABSTRACT: Background. Hemodialysis (HD) patients with functional iron deficiency (FID) often develop resistance to recombinant human erythropoietin (rHuEpo). In these patients, iron therapy may be a hazard, leading to iron…